Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy

Autor: Prince, H.M., Bashford, J., Wall, D., Rischin, D., Parker, N., Toner, G.C., Seymour, J.F., Blakey, D., Haylock, D., Simmons, P., Francis, P., Wolf, M., Januszewicz, E.H., Richardson, G., Scarlett, J., Briggs, P.
Zdroj: In Cytotherapy March 2002 4(2):137-145
Databáze: ScienceDirect